OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IMRX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Immuneering (IMRX) Earnings Date & Reports

Immuneering Corp is a biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IMRX is expected to report earnings to fall 5.50% to -37 cents per share on November 06

Q3'25

Est.

$-0.38

Q2'25

Beat

by $0.02

Q1'25

Beat

by $0.05

Q4'24

Missed

by $0.13

Q3'24

Beat

by $0.06

The last earnings report on August 13 showed earnings per share of -40 cents, beating the estimate of -41 cents. With 594.02K shares outstanding, the current market capitalization sits at 229.05M.

View a ticker or compare two or three

Compare

IMRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IMRX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMRX showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

245 Main Street

Phone

+1 617 500-8080

Employees

Web

https://www.immuneering.com